Longo DL - Search Results

1

Radiation therapy versus combination chemotherapy in the treatment of early-stage Hodgkin's disease: seven-year results of a prospective randomized trial.

Longo DL, Glatstein E, Duffey PL, Young RC, Hubbard SM, Urba WJ, Wesley MN, Raubitschek A, Jaffe ES, Wiernik PH, et al. Longo DL, et al. J Clin Oncol. 1991 Jun;9(6):906-17. doi: 10.1200/JCO.1991.9.6.906. J Clin Oncol. 1991. PMID: 2033427 Clinical Trial.

2

Radiation therapy is better than chemotherapy in early-stage Hodgkin's disease? Not so fast.

Longo DL, Duffey PL, Hubbard SM, Young RC, DeVita VT Jr. Longo DL, et al. J Clin Oncol. 1992 Aug;10(8):1367-9. doi: 10.1200/JCO.1992.10.8.1367. J Clin Oncol. 1992. PMID: 1634930 No abstract available.

3

Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial.

Longo DL, DeVita VT Jr, Duffey PL, Wesley MN, Ihde DC, Hubbard SM, Gilliom M, Jaffe ES, Cossman J, Fisher RI, et al. Longo DL, et al. J Clin Oncol. 1991 Jan;9(1):25-38. doi: 10.1200/JCO.1991.9.1.25. J Clin Oncol. 1991. PMID: 1702144 Clinical Trial.

4

Long-term follow-up of ProMACE-CytaBOM in non-Hodgkin's lymphomas.

Fisher RI, Longo DL, DeVita VT Jr, Hubbard SM, Miller TP, Young RC. Fisher RI, et al. Among authors: longo dl. Ann Oncol. 1991 Jan;2 Suppl 1:33-5. doi: 10.1093/annonc/2.suppl_1.33. Ann Oncol. 1991. PMID: 1710487 Free article. Review.

5

Treatment of advanced-stage Hodgkin's disease: alternating noncrossresistant MOPP/CABS is not superior to MOPP.

Longo DL, Duffey PL, DeVita VT Jr, Wiernik PH, Hubbard SM, Phares JC, Bastian AW, Jaffe ES, Young RC. Longo DL, et al. J Clin Oncol. 1991 Aug;9(8):1409-20. doi: 10.1200/JCO.1991.9.8.1409. J Clin Oncol. 1991. PMID: 1712836 Clinical Trial.

6

Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure.

Longo DL, Duffey PL, Young RC, Hubbard SM, Ihde DC, Glatstein E, Phares JC, Jaffe ES, Urba WJ, DeVita VT Jr. Longo DL, et al. J Clin Oncol. 1992 Feb;10(2):210-8. doi: 10.1200/JCO.1992.10.2.210. J Clin Oncol. 1992. PMID: 1732422

7

Hodgkin's disease.

Urba WJ, Longo DL. Urba WJ, et al. Among authors: longo dl. N Engl J Med. 1992 Mar 5;326(10):678-87. doi: 10.1056/NEJM199203053261006. N Engl J Med. 1992. PMID: 1736106 Review. No abstract available.

8

Treatment-related morbidity in patients with lymphoma.

Hubbard SM, Longo DL. Hubbard SM, et al. Among authors: longo dl. Curr Opin Oncol. 1991 Oct;3(5):852-62. doi: 10.1097/00001622-199110000-00008. Curr Opin Oncol. 1991. PMID: 1751579 Review.

9

The calculation of actual or received dose intensity: a comparison of published methods.

Longo DL, Duffey PL, DeVita VT Jr, Wesley MN, Hubbard SM, Young RC. Longo DL, et al. J Clin Oncol. 1991 Nov;9(11):2042-51. doi: 10.1200/JCO.1991.9.11.2042. J Clin Oncol. 1991. PMID: 1941063

10

Treatment of advanced-stage massive mediastinal Hodgkin's disease: the case for combined modality treatment.

Longo DL, Russo A, Duffey PL, Hubbard SM, Glatstein E, Hill JB, Jaffe ES, Young RC, DeVita VT Jr. Longo DL, et al. J Clin Oncol. 1991 Feb;9(2):227-35. doi: 10.1200/JCO.1991.9.2.227. J Clin Oncol. 1991. PMID: 1988570

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

787 results

Search Page